Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Gibbons

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophyEmily Gibbons, Daniel Whittam, Kariem Elhadd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2024
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosisChiara Rocchi, Mirasol Forcadela, Patricia Kelly, et al.
Journal of Pediatrics. Clinical Practice|December 24, 2025
The Effect of Body Position on Oxygenation, Ventilation, and Diaphragmatic Workload in Infants Born Premature on Noninvasive Neurally Adjusted Ventilatory AssistNada Darwish, Emily Gibbons, Omar Abdulrazzaq, et al.
Annals of Clinical and Translational Neurology|June 17, 2024
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorderAnna Francis, Emily Gibbons, Jeffrey Yu, et al.
Academic Pediatrics|January 30, 2026
Knowledge and training about caring for children with intrauterine opioid exposure: A multisite pediatrician surveyKatherine E Shedlock, Neera K Goyal, Neera Shah Demharter, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
Multiple Sclerosis and Related Disorders|January 26, 2024
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort studyDaniel Lordelo San Martin, Thiago Gonçalves Fukuda, Thiago Santos Nascimento, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2022
Progressive myelin oligodendrocyte glycoprotein-associated demyelination mimicking leukodystrophyEmily Gibbons, Daniel Whittam, Kariem Elhadd, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2024
The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosisChiara Rocchi, Mirasol Forcadela, Patricia Kelly, et al.
Journal of Pediatrics. Clinical Practice|December 24, 2025
The Effect of Body Position on Oxygenation, Ventilation, and Diaphragmatic Workload in Infants Born Premature on Noninvasive Neurally Adjusted Ventilatory AssistNada Darwish, Emily Gibbons, Omar Abdulrazzaq, et al.
Annals of Clinical and Translational Neurology|June 17, 2024
Characterizing mortality in patients with AQP4-Ab+ neuromyelitis optica spectrum disorderAnna Francis, Emily Gibbons, Jeffrey Yu, et al.
Academic Pediatrics|January 30, 2026
Knowledge and training about caring for children with intrauterine opioid exposure: A multisite pediatrician surveyKatherine E Shedlock, Neera K Goyal, Neera Shah Demharter, et al.
Journal of Neurology|July 27, 2024
Assessment of international MOGAD diagnostic criteria in patients with overlapping MOG-associated disease and multiple sclerosis phenotypesGiovanna S Manzano, Michael Levy, Rebecca Salky, et al.
Multiple Sclerosis and Related Disorders|January 26, 2024
Predictors of azathioprine and mycophenolate mofetil response in patients with neuromyelitis optica spectrum disorder: A cohort studyDaniel Lordelo San Martin, Thiago Gonçalves Fukuda, Thiago Santos Nascimento, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody diseaseItay Lotan, John J Chen, Yael Hacohen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
American Journal of Respiratory and Critical Care Medicine|August 9, 2023
A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated <i>Streptococcus pneumoniae</i> Strains Using Human Infection ChallengeHelen Hill, Elena Mitsi, Elissavet Nikolaou, et al.
Pageof 3